319
Participants
Start Date
October 31, 2015
Primary Completion Date
October 31, 2016
Study Completion Date
October 31, 2016
Dasotraline
Dasotraline 4, 6, 8mg flexibly dosed once daily
Placebo
Placebo once daily
Bioscience Research, LLC, Mount Kisco
Lehigh Center For Clinical Research, Allentown
NeuroScience, Inc., Herndon
Wake Research Associates, Raleigh
Radiant Research, Inc., Anderson
Radiant Research, Inc., Greer
Institute of Advanced Medical Research, Alpharetta
Neurotrials Research, INC., Atlanta
Clinical Neuroscience Solutions, Inc., Jacksonville
Clinical Neuroscience Solutions, Inc., Orlando
Miami Research Associates, South Miami
Segal Institute for Clinical Research, North Miami
North Star Medical Research, LLC, Middleburg Heights
Radiant Research, Inc., Akron
Lindner Center Of Hope, Mason
Patient Priority Clinical Sites, Cincinnati
Midwest Clinical Research Center, Dayton
Goldpoint Clinical Research, Inc., Indianapolis
Capstone Clinical Research, Libertyville
St. Charles Psychiatric Associates - Midwest Research Group, Saint Charles
Cypress Medical Research Center, LLC, Wichita
IPS Research Company, Oklahoma City
Psychiatric Medical Associates, Plano
Furturesearch Trials of Dallas, Dallas
Texas Center for Drug Development, Inc., Houston
Lytle and Weiss, PLLC, Denver
Radiant Research, Inc., Murray
Advanced Research Institute, Ogden
Southern California Research, Beverly Hills
Southwestern Research, Inc., Beverly Hills
Pharmacology Research Institute, Encino
PCSD- Feighner Research, San Diego
Pharmacology Research Institute, Newport Beach
Research Across America, Santa Ana
Collaborative NeuroScience Network Inc., Garden Grove
Oregon Center for Clinical Investigatons, INC., Portland
Oregon Center for Clinical Investigatons, INC., Salem
Sunstone Medical Research, LLC, Medford
Summit Research Network (Seattle) LLC, Seattle
McLean Hospital, Belmont
Adams Clinical Trials, LLC, Watertown
Princeton Medical Institute, LCC, Princeton
Neuropsychiatric Associates, Woodstock
Sumitomo Pharma America, Inc.
INDUSTRY